Dr. James M. Ford, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Stanford, CA
He has not yet shared a personalized biography with Doctor.com.
Institution | Focus | Year |
---|---|---|
Internship - Stanford University School Med | 1990 | |
Internship - Stanford University Medical Center, Stanford Ca - Bariatric Surgery | 1990 | |
Residency - Stanford University School of Medicine | 1991 | |
Fellowship - Stanford University School of Medicine,Stanford, Ca, United States | 1994 |
Certification | Cert. Body | Year |
---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 2005 |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | JOURL OF CLINICAL ONCOLOGY | Molecular Profiling of Gastric Cancer: Toward Persolized Cancer Medicine | 2013 |
Other Publication | SCIENCE TRANSLATIOL MEDICINE | Lupus Antibody Tops Cancer Cells | 2012 |
Other Publication | JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION | Lynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack | 2012 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Long-Term Survivors of Gastric Cancer: A California Population-Based Study | 2012 |
Other Publication | CANCER JOURL | Genetic Testing by Cancer Site Stomach | 2012 |
Other Publication | D REPAIR | Breast cancers with compromised D repair exhibit selective sensitivity to elesclomol | 2012 |
Other Publication | ANLS OF INTERL MEDICINE | Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost | 2011 |
Other Publication | JOURL OF THE TIOL CANCER INSTITUTE | Second Primary Breast Cancer Occurrence According to Hormone Receptor Status | 2009 |
Other Publication | CANCER RESEARCH | Defective Repair of Oxidative D Damage in Triple | 2009 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Performance of BRCA1/2 mutation prediction models in Asian Americans | 2008 |
Other Publication | ANLS OF SURGERY | CDH1 truncating mutations in the E-cadherin gene | 2007 |
Other Publication | JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION | Predicting and preventing hereditary colorectal cancer | 2006 |
Other Publication | CANCER RESEARCH | Molecular inversion probe alysis of gene copy alterations reveals distinct categories of colorectal | 2006 |
Other Publication | EMBO JOURL | Opposing effects of the UV lesion repair protein XPA | 2006 |
Other Publication | JOURL OF BIOLOGICAL CHEMISTRY | In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product | 2003 |
Other Publication | D REPAIR | p53 and regulation of D damage recognition during nucleotide excision repair | 2003 |
Other Publication | D REPAIR | The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair | 2003 |
Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | p53 and D damage-inducible expression of the xeroderma pigmentosum group C gene | 2002 |
Other Publication | TURE GENETICS | BRCA1 induces D damage recognition factors and enhances nucleotide excision repair | 2002 |
Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Expression of the p48 xeroderma pigmentosum gene is p53-dependent | 1999 |
Other Publication | JOURL OF BIOLOGICAL CHEMISTRY | Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in | 1997 |
Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | LI-FRAUMENI SYNDROME FIBROBLASTS HOMOZYGOUS FOR P53 MUTATIONS ARE DEFICIENT IN GLOBAL D | 1995 |
Other Publication | Jourl of the American Medical Informatics Association | Dymic contrast-enhanced MRI | 2013 |
Other Publication | Jourl of the tiol Comprehensive Cancer Network | A young woman with bilateral breast cancer | 2013 |
Other Publication | ANLS OF SURGICAL ONCOLOGY | Seventh Edition (2010) of the AJCC | 2013 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early | 2012 |
Other Publication | PLOS ONE | Single Cell Profiling of Circulating Tumor Cells | 2012 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Family History As a Positive Prognostic Factor in Gastric Cancer | 2012 |
Other Publication | Genes & cancer | Identification of a Functiol In Vivo p53 Response Element | 2012 |
Other Publication | ANLS OF SURGICAL ONCOLOGY | A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer | 2011 |
Other Publication | CANCER | Intensity-Modulated Radiation Therapy Versus Conventiol Radiation Therapy for Squamous Cell | 2011 |
Other Publication | Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No | Comparison of Intensity-Modulated Radiotherapy | 2010 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION | 2010 |
Other Publication | CANCER RESEARCH | Oncogenic BRAF Mutation with CDKN2A Ictivation Is Characteristic of a Subset of Pediatric Malignt | 2010 |
Other Publication | JOURL OF TRANSLATIOL MEDICINE | Identification of a biomarker panel using a multiplex proximity ligation | 2009 |
Other Publication | D REPAIR | The role of the retinoblastoma | 2009 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Gemcitabine chemotherapy | 2008 |
Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | Microsatellite instability | 2008 |
Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1) | 2008 |
Other Publication | BREAST JOURL | Magnetic resonce galactography | 2008 |
Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombition | 2007 |
Other Publication | JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION | Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer | 2007 |
Other Publication | BREAST JOURL | Ductal pattern enhancement on magnetic resonce imaging of the breast due to ductal lavage | 2007 |
Other Publication | MOLECULAR CELL | A kise-independent function of c | 2006 |
Other Publication | Jourl of the tiol Comprehensive Cancer Network | Colorectal Cancer Screening Clinical Practice Guidelines. | 2006 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II study to assess the efficacy of conventiolly fractioted radiotherapy followed by a | 2005 |
Other Publication | MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | Regulation of D damage recognition and nucleotide excision repair: Another role for p53 | 2005 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Phase II study of gefitinib, fluorouracil | 2005 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer | 2004 |
Other Publication | CANCER | Breast magnetic resonce image screening | 2004 |
Other Publication | MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH | Functiol characterization of global genomic D repair and its implications for cancer | 2003 |
Other Publication | JOURL OF MOLECULAR MEDICINE-JMM | BRCA1 and p53: compensatory roles in D repair | 2003 |
Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Defective double-strand D break repair and chromosomal translocations by MYC overexpression | 2003 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil | 2003 |
Other Publication | Jourl of biomedicine & biotechnology | D Damage, Repair, and Diseases. | 2002 |
Other Publication | JOURL OF BIOLOGICAL CHEMISTRY | The p53-regulated cyclin-dependent kise inhibitor | 2001 |
Other Publication | AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5 | 2001 |
Other Publication | Mehta, V. K., Fisher, G., Ford, J. A., Poen, J. C., Vierra, M. A., Obe | Preoperative chemoradiation for margilly resectable adenocarcinoma of the pancreas | 2001 |
Other Publication | ARCHIVES OF SURGERY | Adjuvant chemoradiotherapy for unfavorable carcinoma of the ampulla of vater - Prelimiry report | 2001 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Adjuvant radiotherapy | 2000 |
Other Publication | MUTATION RESEARCH-D REPAIR | Decreased UV sensitivity | 2000 |
Other Publication | MOLECULAR AND CELLULAR BIOLOGY | p53-mediated D repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and | 2000 |
Other Publication | ANLS OF SURGICAL ONCOLOGY | Chemoradiotherapy in the magement of localized tumors of the pancreas | 1999 |
Other Publication | JOURL OF BIOLOGICAL CHEMISTRY | Hepatitis B x protein inhibits p53-dependent D repair in primary mouse hepatocytes | 1998 |
Other Publication | GENETIC INSTABILITY AND TUMORIGENESIS | Role of D excision repair gene defects in the etiology of cancer | 1997 |
Other Publication | EUROPEAN JOURL OF CANCER | Experimental reversal of P-glycoprotein | 1996 |
Other Publication | MOLECULAR CARCINOGENESIS | PREFERENTIAL REPAIR OF ULTRAVIOLET LIGHT-INDUCED D | 1994 |
Other Publication | CANCER LETTERS | MODULATION OF RESISTANCE TO ALKYLATING-AGENTS IN CANCER CELL BY GOSSYPOL ENTIOMERS | 1991 |
Other Publication | MOLECULAR PHARMACOLOGY | BIOCHEMICAL CORRELATES OF THE ANTITUMOR AND ANTIMITOCHONDRIAL PROPERTIES OF GOSSYPOL ENTIOMERS | 1990 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | TOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE | 1989 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Molecular Profiling of Gastric Cancer: Toward Personalized Cancer Medicine | 2013 |
Other Publication | SCIENCE TRANSLATIONAL MEDICINE | Lupus Antibody Tops Cancer Cells | 2012 |
Other Publication | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | Lynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack | 2012 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Long-Term Survivors of Gastric Cancer: A California Population-Based Study | 2012 |
Other Publication | CANCER JOURNAL | Genetic Testing by Cancer Site Stomach | 2012 |
Other Publication | DNA REPAIR | Breast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol | 2012 |
Other Publication | Breast cancer research : BCR | Is breast cancer a part of Lynch syndrome? | 2012 |
Other Publication | ANNALS OF INTERNAL MEDICINE | Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost | 2011 |
Other Publication | BMC pharmacology | Enhanced sensitivity to cisplatin | 2011 |
Other Publication | CANCER RESEARCH | Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly | 2010 |
Other Publication | JOURNAL OF THE NATIONAL CANCER INSTITUTE | Second Primary Breast Cancer Occurrence According to Hormone Receptor Status | 2009 |
Other Publication | CANCER RESEARCH | Defective Repair of Oxidative DNA Damage in Triple | 2009 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Performance of BRCA1/2 mutation prediction models in Asian Americans | 2008 |
Other Publication | CANCER | Hereditary diffuse gastric cancer - Implications of genetic testing for screening | 2008 |
Other Publication | ANNALS OF SURGERY | CDH1 truncating mutations in the E-cadherin gene | 2007 |
Other Publication | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | Predicting and preventing hereditary colorectal cancer | 2006 |
Other Publication | CANCER RESEARCH | Molecular inversion probe analysis of gene copy alterations reveals distinct categories of | 2006 |
Other Publication | EMBO JOURNAL | Opposing effects of the UV lesion repair protein XPA | 2006 |
Other Publication | JOURNAL OF BIOLOGICAL CHEMISTRY | In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product | 2003 |
Other Publication | DNA REPAIR | p53 and regulation of DNA damage recognition during nucleotide excision repair | 2003 |
Other Publication | DNA REPAIR | The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair | 2003 |
Other Publication | CARCINOGENESIS | p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53 | 2003 |
Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene | 2002 |
Other Publication | NATURE GENETICS | BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair | 2002 |
Other Publication | MOLECULAR CELL | Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis | 2000 |
Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Expression of the p48 xeroderma pigmentosum gene is p53-dependent | 1999 |
Other Publication | JOURNAL OF BIOLOGICAL CHEMISTRY | Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in | 1997 |
Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | LI-FRAUMENI SYNDROME FIBROBLASTS HOMOZYGOUS FOR P53 MUTATIONS ARE DEFICIENT IN GLOBAL DNA | 1995 |
Other Publication | Breast cancer research and treatment | A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. | 2013 |
Other Publication | Journal of the American Medical Informatics Association | Dynamic contrast-enhanced MRI | 2013 |
Other Publication | Journal of the National Comprehensive Cancer Network | A young woman with bilateral breast cancer | 2013 |
Other Publication | ANNALS OF SURGICAL ONCOLOGY | Seventh Edition (2010) of the AJCC | 2013 |
Other Publication | FAMILIAL CANCER | Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations | 2012 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early | 2012 |
Other Publication | MODERN PATHOLOGY | Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma | 2012 |
Other Publication | PLOS ONE | Single Cell Profiling of Circulating Tumor Cells | 2012 |
Other Publication | Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., | Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma | 2012 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Family History As a Positive Prognostic Factor in Gastric Cancer | 2012 |
Other Publication | Genes & cancer | Identification of a Functional In Vivo p53 Response Element | 2012 |
Other Publication | BioDiscovery | Identification of a novel deletion mutant strain in Saccharomyces cerevisiae that results in a | |
Other Publication | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population | 2012 |
Other Publication | ANNALS OF SURGICAL ONCOLOGY | A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer | 2011 |
Other Publication | CANCER | Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell | 2011 |
Other Publication | MODERN PATHOLOGY | A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal | 2011 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry | 2011 |
Other Publication | Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A. | Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate | 2010 |
Other Publication | CLINICAL CANCER RESEARCH | Poly(ADP-Ribose) Polymerase Inhibition: Targeted Therapy for Triple-Negative Breast Cancer | 2010 |
Other Publication | Clinical advances in hematology & oncology : H&O | PARP inhibitors in breast cancer. | 2010 |
Other Publication | Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No | Comparison of Intensity-Modulated Radiotherapy | 2010 |
Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION | 2010 |
Other Publication | HUMAN PATHOLOGY | Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation | 2010 |
Other Publication | COLORECTAL DISEASE | Pathological response after chemoradiation for T3 rectal cancer | 2010 |
Other Publication | Colorectal disease | Pathological response after chemoradiation for T3 rectal cancer. | 2010 |
Other Publication | CLINICAL BREAST CANCER | Novel Treatment Approaches for Triple-Negative Breast Cancer | 2010 |
Other Publication | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | Longer Relative Telomere Length in Blood from Women with Sporadic | 2010 |
Other Publication | CANCER RESEARCH | Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric | 2010 |
Other Publication | Current breast cancer reports | PARP Inhibitors for the Treatment and Prevention of Breast Cancer. | 2010 |
Other Publication | DISEASES OF THE ESOPHAGUS | Multimodality treatment with intensity modulated radiation therapy for esophageal cancer | 2010 |
Other Publication | JOURNAL OF TRANSLATIONAL MEDICINE | Identification of a biomarker panel using a multiplex proximity ligation | 2009 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | A BRCA2 founder mutation | 2009 |
Other Publication | DNA REPAIR | The role of the retinoblastoma | 2009 |
Other Publication | CLINICAL NUCLEAR MEDICINE | Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT | 2009 |
Other Publication | CANCER | Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas | 2009 |
Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Gemcitabine chemotherapy | 2008 |
Other Publication | AMERICAN JOURNAL OF SURGICAL PATHOLOGY | Microsatellite instability | 2008 |
Other Publication | FAMILIAL CANCER | Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers | 2008 |
Other Publication | AMERICAN JOURNAL OF SURGICAL PATHOLOGY | Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1) | 2008 |
Other Publication | FAMILIAL CANCER | Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family | 2008 |
Other Publication | PEDIATRIC BLOOD & CANCER | Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family | 2008 |
Other Publication | BREAST JOURNAL | Magnetic resonance galactography | 2008 |
Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination | 2007 |
Other Publication | CANCER GENETICS AND CYTOGENETICS | A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature | 2007 |
Other Publication | GENETICS IN MEDICINE | Identification of an intronic single nucleotide polymorphism leading to allele dropout during | 2007 |
Other Publication | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer | 2007 |
Other Publication | BREAST JOURNAL | Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage | 2007 |
Other Publication | MOLECULAR PHARMACOLOGY | Reversal of stathmin-mediated resistance to paclitaxel | 2007 |
Other Publication | CLINICAL CANCER RESEARCH | Germ line mutations of mismatch repair genes | 2006 |
Other Publication | MOLECULAR CELL | A kinase-independent function of c | 2006 |
Other Publication | Journal of the National Comprehensive Cancer Network | Colorectal Cancer Screening Clinical Practice Guidelines. | 2006 |
Other Publication | Daly, M. B., Axilbund, J. E., Bryant, E., Buys, S., Eng, C., Friedman, | Genetic/familial high-risk assessment: breast and ovarian. | |
Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a | 2005 |
Other Publication | MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | Regulation of DNA damage recognition and nucleotide excision repair: Another role for p53 | 2005 |
Other Publication | HEALTH EXPECTATIONS | Opinions of women with high inherited breast cancer risk about prophylactic mastectomy | 2005 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Phase II study of gefitinib, fluorouracil | 2005 |
Other Publication | CLINICAL CANCER RESEARCH | Characterization of a recurrent germ line mutation of the E-cadherin gene | 2005 |
Other Publication | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | Ductal lavage of fluid-yielding and non | 2005 |
Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer | 2004 |
Other Publication | CANCER | Breast magnetic resonance image screening | 2004 |
Other Publication | MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH | Functional characterization of global genomic DNA repair and its implications for cancer | 2003 |
Other Publication | JOURNAL OF MOLECULAR MEDICINE-JMM | BRCA1 and p53: compensatory roles in DNA repair | 2003 |
Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression | 2003 |
Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil | 2003 |
Other Publication | Journal of biomedicine & biotechnology | DNA Damage, Repair, and Diseases. | 2002 |
Other Publication | JOURNAL OF BIOLOGICAL CHEMISTRY | The p53-regulated cyclin-dependent kinase inhibitor | 2001 |
Other Publication | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5 | 2001 |
Other Publication | Mehta, V. K., Poen, J., Ford, J., Edelstein, P. S., Vierra, M., Bastid | Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil | 2001 |
Other Publication | Mehta, V. K., Fisher, G., Ford, J. A., Poen, J. C., Vierra, M. A., Obe | Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas | 2001 |
Other Publication | ARCHIVES OF SURGERY | Adjuvant chemoradiotherapy for unfavorable carcinoma of the ampulla of vater - Preliminary report | 2001 |
Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Adjuvant radiotherapy | 2000 |
Other Publication | MOLECULAR AND CELLULAR BIOLOGY | Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53 | 2000 |
Other Publication | MOLECULAR CARCINOGENESIS | Reduced global genomic repair of ultraviolet light | 2000 |
Other Publication | MUTATION RESEARCH-DNA REPAIR | Decreased UV sensitivity | 2000 |
Other Publication | MOLECULAR AND CELLULAR BIOLOGY | p53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and | 2000 |
Other Publication | ANNALS OF SURGICAL ONCOLOGY | Chemoradiotherapy in the management of localized tumors of the pancreas | 1999 |
Other Publication | JOURNAL OF BIOLOGICAL CHEMISTRY | Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes | 1998 |
Other Publication | CANCER RESEARCH | Human fibroblasts expressing the human papillomavirus E6 gene are deficient | 1998 |
Other Publication | GENETIC INSTABILITY AND TUMORIGENESIS | Role of DNA excision repair gene defects in the etiology of cancer | 1997 |
Other Publication | EUROPEAN JOURNAL OF CANCER | Experimental reversal of P-glycoprotein | 1996 |
Other Publication | Cancer treatment and research | P-glycoprotein-mediated multidrug resistance | 1996 |
Other Publication | HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | MODULATORS OF MULTIDRUG-RESISTANCE - PRECLINICAL STUDIES | 1995 |
Other Publication | MOLECULAR CARCINOGENESIS | PREFERENTIAL REPAIR OF ULTRAVIOLET LIGHT-INDUCED DNA | 1994 |
Other Publication | CYTOTECHNOLOGY | PHARMACOLOGICAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE | 1993 |
Other Publication | CANCER RESEARCH | EFFECT OF BUTHIONINE SULFOXIMINE ON TOXICITY OF VERAPAMIL AND DOXORUBICIN TO MULTIDRUG RESISTANT | 1991 |
Other Publication | CANCER LETTERS | MODULATION OF RESISTANCE TO ALKYLATING-AGENTS IN CANCER CELL BY GOSSYPOL ENANTIOMERS | 1991 |
Other Publication | PHARMACOLOGICAL REVIEWS | PHARMACOLOGY OF DRUGS THAT ALTER MULTIDRUG RESISTANCE IN CANCER | 1990 |
Other Publication | MOLECULAR PHARMACOLOGY | BIOCHEMICAL CORRELATES OF THE ANTITUMOR AND ANTIMITOCHONDRIAL PROPERTIES OF GOSSYPOL ENANTIOMERS | 1990 |
Other Publication | CANCER RESEARCH | CELLULAR AND BIOCHEMICAL | 1990 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | TOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE | 1989 |
Other Publication | MOLECULAR PHARMACOLOGY | STRUCTURAL FEATURES DETERMINING ACTIVITY OF PHENOTHIAZINES AND RELATED DRUGS FOR INHIBITION OF CELL | 1989 |
Dr. James M. Ford, MD has not yet indicated the hospitals that he is affiliated with.
Accepts New Patients: Yes
Dr. James M. Ford, MD has not yet listed the medications that he commonly prescribes.
Dr. James M. Ford, MD has not yet added any information about his practice's billing policies and payment options.